The Imaging Translation Program is accelerating the development of imaging tools and techniques for earlier detection, diagnosis and treatment of cancer. Targeted imaging probes are one type of the specialized tools being developed. The Program aims to streamline advances into the clinic and marketplace to improve screening and treatment options for cancer patients.
The Imaging Translation Program was established to address the fact that no imaging group in Ontario has all the necessary components to translate innovation through the complex pipeline from discovery to clinical translation and commercialization. This has presented a practical impediment to further progress or at least has markedly slowed progress. The Imaging Translation Program’s goal is to increase Ontario's capability to accelerate the translation of research into the development of new imaging probes for early cancer detection into clinical practice. This process involves several critical stages, which are the foci of the four projects found below.
Imaging Translation Program Fact Sheet
Lead Principal Investigator
Dr. Martin Yaffe
Dr. Aaron Fenster
Molecular imaging enables physicians to visualize non-invasively the biochemical changes in cells that lead ...
Second only to skin cancer, prostate cancer is the most commonly diagnosed cancer and the third highest cause ...
The Pathology Validation Project is carried out as a joint project between OICR and the Centre for Imaging ...
The treatment of cancer promises to undergo a revolution, wherein, very specific measurements or biomarkers ...